10th UMOS Conference

Oncology Meeting Resources

16 May - 17 May, Belgrade, Serbia

In 2015, the UMOS (Serbian Society of Medical Oncology) Conference focused on "Breast cancer as a fast moving target: What are the most important treatment and diagnosis updates during the last 2 years?".

On this page, you may view the slide sets of presentations given at the 10th UMOS Conference to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Useful Links

Presenter Presentation title Session title
F. Cardoso Guidelines for the treatments of LABC and MBC ABC2 Metastatic process-basic overview
R. Janković Liquid biopsy: Tumor diagnosis and treatment monitoring in a blood test Metastatic process-basic overview
S. Šušnjar Bone marrow metastases/impact on disease outcome Specific metastatic sites: focus on bone metastases
T. Badovinac - Crnjević Prevention of bone metastases: role of adjuvant bisphosphonates Specific metastatic sites: focus on bone metastases
M. Milović - Kovačević Prevention of bone metastases: role of RANKL inhibitor denosumab Specific metastatic sites: focus on bone metastases
Z. Tomašević General mechanisms of drug resistance: focus on chemotherapy Why metastatic breast cancer is not curable?
Lj. Stamatović Mechanism of hormone drug resistance Why metastatic breast cancer is not curable?
Z. I. Tomašević Mechanism of monoclonal antibody drug resistance: focus on trastuzumab Why metastatic breast cancer is not curable?
LS. Vasović Mechanisms of TKIs drug resistance: focus on lapatinib Why metastatic breast cancer is not curable?
G. Curigliano Overview of anti-HER2 options Specific subtypes: HER2 positive BC
A. Filipović Bad news or might be not? Specific subtypes: triple negative BC
Z. Murtezani Chemotherapy: is better to use platinum agents and why? Specific subtypes: triple negative BC
I. Božović - Spasojević Biology therapy (PARP, BEV): a case dismissed? Specific subtypes: triple negative BC
S. Bosnjak Recent advances in the prevention of chemotherapy-induced nausea and vomiting Special lecture
L. Popovic Really young patients (< 30 yrs) (incidence, patient and treatment characteristics) UMOS young oncologists (evaluation of specific issues)